01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
The City of Columbus is open for business (remotely) to accept and review zoning, site plan, and per...
Read More >
Former PG&E lawyer named new regional EPA chief in California - Los Angeles Times – February 11 -...
Read More >
Welcome to the special 10th anniversary celebration of Compliance Man Chooses the Target. In honor o...
Read More >
In Allen v. Ambu-Stat, LLC, No. 18-10640 (January 16, 2020), the U.S. Court of Appeals for the Eleve...
Read More >
California's new law, AB 5, broadens the definition of "employee" by adopting the so-called A-B-C te...
Read More >
On Friday April 17, the federal government (through the Department of Homeland Security’s Cybersecu...
Read More >